Table 6.
Contribution of cellblock in diagnosis of neoplastic and granulomatous cases, and for the subtyping of the neoplastic cases
| Diagnosis | Total cases (%) |
Contribution of CB to diagnosis: No. of cases (%) |
Contribution of CB to subtyping of malignancy: No. of cases (%) |
|||
|---|---|---|---|---|---|---|
| Erer OF et al. (2017)[21] | This study (2017) | Erer OF et al. (2017)[21] | This study (2017) | Erer OF et al. [2017][21] | This study (2017) | |
| Granulomatous | 84 (100) | 87 (100) | 38 (45.2) | 7 (8) | - | - |
| Neoplastic | 179 (100) | 40 (100) | 15 (8.3) | 2 (5) | 19 (10.6) | 19 (47.5) |
| Adenocarcinoma | 62 (34.6) | 13 (32.5) | 2 (1.1) | 1 (2.5) | 12 (6.7) | 7/40 (20) |
| Squamous cell cancer | 52 (29) | 8/40 (20) | 5 (2.7) | 1 (2.5) | 4 (2.2) | 1 (2.5) |
| Small cell lung cancer | 37 (20.6) | 5/40 (12.5) | 2 (1.1) | 0 | 3 (1.6) | 4 (10) |
| Non small cell lung cancer | 12 (6.7) | - | 3 (1.6) | 0 | 0 | - |
| Extra Pulmonary Metastasis | 14 (7.8) | 4 (10.0) | 3 (1.6) | 0 | 0 | 3 (5) |
| Lymphoma | 2 (1.1) | 4 (10) | 0 | 0 | 0 | 2 (5) |
| Adenosquamous carcinoma | - | 1 (2.5) | - | - | - | 0 |
| Primitive Neuroectodermal Tumour | - | 2 (5) | - | 0 | - | 1 (2.5) |
| Mesenchymal Neoplasm (Leiomyoma) | - | 1 (2.5) | - | - | - | 1 (2.5) |
| Epithelial Neoplasm. NOS | - | 2 | - | 0 | - | 0 |